TrademarkDir
INTROGEN
DEAD

Serial Number

74568410

Owner

Introgen Therapeutics, Inc.

Attorney

William D. Raman

First Use Date

Feb 14, 1996

Filing Date

Sep 1, 1994

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

INTROGEN Trademark

Serial Number: 74568410 • Registration: 2001851

INTROGEN is a trademark filed by Introgen Therapeutics, Inc. on September 1, 1994. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Introgen Therapeutics, Inc. (3 trademarks)

301 Congress Avenue, Suite 2025
Austin, TX 78701

Entity Type: 03

Trademark Details

Filing Date

September 1, 1994

Registration Date

September 17, 1996

First Use Anywhere

February 14, 1996

First Use in Commerce

February 14, 1996

Published for Opposition

August 1, 1995

Cancellation Date

April 17, 2020

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Apr 17, 2020 CAEX
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 5, 2006 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 5, 2006 89AG
ASSIGNED TO PARALEGAL
Aug 2, 2006 PLGL
CASE FILE IN TICRS
Jun 29, 2006 CFIT
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
May 8, 2006 89AF
PAPER RECEIVED
May 8, 2006 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2006 TCCA
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 15, 2003 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Sep 16, 2002 815F
PAPER RECEIVED
Sep 16, 2002 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 8, 2002 TCCA
REGISTERED-PRINCIPAL REGISTER
Sep 17, 1996 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 22, 1996 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 12, 1996 SUPC
USE AMENDMENT FILED
Apr 4, 1996 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 1995 NOAM
PUBLISHED FOR OPPOSITION
Aug 1, 1995 PUBO
NOTICE OF PUBLICATION
Jun 30, 1995 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 1995 CNSA
ASSIGNED TO EXAMINER
Jan 27, 1995 DOCK

Related Trademarks

More from this Owner

ADVECTIN

ADVECTIN

ADVEXIN

ADVEXIN